Last quarter (Q3 2023), EyePoint Pharmaceuticals's total revenue was $15.20M, an increase of 51.84% from the same quarter last year. In Q3, EyePoint Pharmaceuticals's net income was $-12.61M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Jun 18
Total Revenue	$ 38.69M	$ 41.40M	$ 36.94M	$ 34.44M	$ 20.36M	$ 2.96M
Cost of Revenue	-	-	-	$ 5.82M	$ 2.69M	$ 0.00
Gross Profit	$ 42.52M	$ 41.40M	$ 36.94M	$ 28.61M	$ 17.68M	$ 2.96M
Operating Expense	$ 57.13M	$ -141.04M	$ 92.22M	$ 65.90M	$ 65.54M	$ 29.23M
Operating Income	$ -78.17M	$ -78.94M	$ -55.28M	$ -37.29M	$ -47.86M	$ -26.27M
Net Non Operating Interest Income Expense	$ -2.03M	$ -3.19M	$ -5.50M	$ -7.20M	$ -5.12M	$ -619.00K
Other Income Expense	$ -2.20M	$ -572.00K	$ -2.36M	$ -905.00K	$ -3.81M	$ -26.28M
Pretax Income	$ -94.16M	$ -102.25M	$ -58.42M	$ -45.39M	$ -56.79M	$ -53.17M
Tax Provision	$ 842.00K	$ -842.00K	-	-	-	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -100.15M	$ -102.25M	$ -58.42M	$ -45.39M	$ -56.79M	$ -53.17M
Basic EPS	$ -4.59M	$ -2.74	$ -2.03	$ -3.54	$ -5.40	$ -11.50
Diluted EPS	$ -2.67	$ -2.74	$ -2.03	$ -3.54	$ -5.40	$ -11.50
Basic Average Shares	$ 150.72M	$ 37.32M	$ 28.76M	$ 12.84M	$ 10.43M	$ 4.62M
Diluted Average Shares	$ 150.72M	$ 37.32M	$ 28.76M	$ 12.84M	$ 10.43M	$ 4.62M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 57.13M	$ -141.04M	$ 92.22M	$ 71.73M	$ 68.23M	$ 29.23M
Net Income From Continuing And Discontinued Operation	$ -100.15M	$ -102.25M	$ -58.42M	$ -45.39M	$ -56.79M	$ -53.17M
Normalized Income	$ -23.34M	-	-	$ -44.49M	$ -52.98M	$ -26.89M
Interest Expense	-	-	-	$ 7.26M	$ 6.18M	$ 720.00K
EBIT	$ -92.13M	$ -99.06M	$ -52.92M	$ -38.14M	$ -50.62M	$ -52.45M
EBITDA	$ -49.11M	$ -96.57M	$ -50.11M	$ -35.49M	$ -48.01M	$ -51.30M

Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing